The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis.
about
The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysisNestin: a novel angiogenesis marker and possible target for tumor angiogenesisTumor heterogeneity and resistance to EGFR-targeted therapy in advanced nonsmall cell lung cancer: challenges and perspectivesMolecular pathways: not a simple tube--the many functions of blood vesselsFlattened microvessel independently predicts poor prognosis of patients with non-small cell lung cancer.Demonstrating Intertumoural Differences in Vascular-Metabolic Phenotype with Dynamic Contrast-Enhanced CT-PETExpression of 15-hydroxyprostaglandin dehydrogenase and cyclooxygenase-2 in non-small cell lung cancer: Correlations with angiogenesis and prognosisAntitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts.Individual participant data meta-analysis of prognostic factor studies: state of the art?Prognostic role of microvessel density in patients with renal cell carcinoma: a meta-analysis.Bevacizumab: the evidence for its clinical potential in the treatment of nonsmall cell lung cancer.Nestin in gastrointestinal and other cancers: effects on cells and tumor angiogenesis.Anti-angiogenic agents in the treatment of non-small cell lung cancer.Role of AFP mRNA expression in peripheral blood as a predictor for postsurgical recurrence of hepatocellular carcinoma: a systematic review and meta-analysis.Rationale for targeting VEGF, FGF, and PDGF for the treatment of NSCLCDual-energy micro-CT functional imaging of primary lung cancer in mice using gold and iodine nanoparticle contrast agents: a validation study.Erlotinib-cisplatin combination inhibits growth and angiogenesis through c-MYC and HIF-1α in EGFR-mutated lung cancer in vitro and in vivo.Molecular mechanisms of angiogenesis in non-small cell lung cancer, and therapeutics targeting related molecules.Prognostic significance of angiogenesis and angiogenic growth factors in nonsmall cell lung cancerThe role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literaturePD-L1 over-expression and survival in patients with non-small cell lung cancer: a meta-analysis.Predicting adenocarcinoma recurrence using computational texture models of nodule components in lung CT.Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer.The role of SOX-2 on the survival of patients with non-small cell lung cancerKi-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysisExpression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic adenocarcinoma: correlation with microvessel density.ZD6474--clinical experience to date.Therapeutic targeting of receptor tyrosine kinases in lung cancer.Acute vascular response to cediranib treatment in human non-small-cell lung cancer xenografts with different tumour stromal architecture.Continuous Low-Dose Temozolomide Chemotherapy and Microvessel Density in Recurrent Glioblastoma.Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival results.Prognostic value of COX-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysisHypoxia-specific drug tirapazamine does not abrogate hypoxic tumor cells in combination therapy with irinotecan and methylselenocysteine in well-differentiated human head and neck squamous cell carcinoma a253 xenografts.Inhibition of angiogenesis in the treatment of non-small cell lung cancer.Immunohistochemistry in the evaluation of neovascularization in tumor xenograftsWarburg revisited: imaging tumour blood flow and metabolism.Correlation of integrin beta3 mRNA and vascular endothelial growth factor protein expression profiles with the clinicopathological features and prognosis of gastric carcinomaDistinct patterns of angiogenic factor expression as a predictive factor of response to chemotherapy in stage IIIA non-small-cell lung cancer patients.Targeting aromatase and estrogen signaling in human non-small cell lung cancer.Advances in preclinical small molecules for the treatment of NSCLC.
P2860
Q24650902-A5A2E4B6-E4FE-443B-8AAA-76A1E4D34E68Q26824035-6B2E9199-C6AA-4FC4-948F-8CC31953F24BQ27014117-A55B4A10-43BA-4260-A46C-B5557FF939FEQ27025036-12E45F00-0C66-4086-93CE-CE2C545E455BQ33728242-A892F00C-A1DD-4158-AE1C-BFDB0AD9E9C5Q33918475-0A37D43E-1E6E-422E-BE63-4EBF8D56B09BQ34141517-65A743A7-30AF-4F97-81E5-0FAF32BD5063Q34223860-C369C528-8D8B-4C25-88DB-53552493CD4EQ34244162-6E624A05-11E5-4328-B7F0-EB000ED48C38Q34371415-F1149D50-CBB0-4A1C-955B-A9FC9CC4E369Q34450520-07A165BE-5708-4651-8919-4154A9FC246EQ34521363-3E42B03A-934F-4B55-9313-66BF9BD31FFBQ34821321-C839AF50-B5D4-414A-BCED-37ADC90A6228Q35010662-AF0FBFA7-0B91-464F-AA91-ED6A40A60366Q35050210-EE347521-B4C4-4758-A930-0226021B698AQ35092707-D6B28BCD-B326-4C28-9868-74C90F0C2970Q35152542-759715F4-1B13-419D-9D00-412CD1BDBCC0Q35161738-446455A5-91A7-45F0-A3F1-B53B5257056EQ35177011-94FD6E8F-1424-4F00-942E-D01D96726ACFQ35216052-1806B5E4-4FB2-4F3D-AC74-876C1D585B1FQ35256558-082694F9-BF0D-4CBB-B0B6-303C535AB633Q35265542-63A5A6D0-FF34-48B4-A586-9DB7A49563D5Q35587652-7310FFEB-F63D-4A48-B93B-5F6582B3AEBFQ35909244-64733B65-C5B4-4772-998F-4D431616D826Q35951523-0983583C-3D93-4A80-93C6-4EBBE1A3B7D0Q36065891-0179A887-13EF-435D-B817-4C79B0192452Q36146882-F8354013-DB84-4128-B7BE-95EB81D6E960Q36158717-79522F5B-568B-4130-915E-DD06B2A5CDC0Q36270034-2B9D0B58-ADFD-4E9A-A020-F74C27050B40Q36396360-E100FE9C-DF3F-49F7-AE92-4A139517101EQ36512153-26CBD7B9-5FF9-475E-96CA-FB76265FCFA0Q36542246-6D696752-CC60-40E6-AAE3-A24D5066594EQ36787650-2C4A52BE-363B-42D2-B9DD-0D0C3DC77212Q36950548-B750FECD-983B-441F-BE19-51513AFBFE20Q37117116-745FFA34-D30F-4DDA-B60A-6630F17AA87CQ37129062-A8A28AFE-2D00-4B9F-9D68-5446EA623DF3Q37184491-9BF5FA89-B762-4CF5-80E6-D617DBA3FDF0Q37288259-BFCF1F71-3BF7-4DBF-B07B-AC84C184B4C5Q37435616-1121F24B-72DD-4A2C-BEA3-76E4DD0D8041Q37489942-8D0CFA13-E07D-40CD-A0DD-F226DF42A507
P2860
The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
The role of microvessel densit ...... literature with meta-analysis.
@ast
The role of microvessel densit ...... literature with meta-analysis.
@en
The role of microvessel densit ...... literature with meta-analysis.
@nl
type
label
The role of microvessel densit ...... literature with meta-analysis.
@ast
The role of microvessel densit ...... literature with meta-analysis.
@en
The role of microvessel densit ...... literature with meta-analysis.
@nl
prefLabel
The role of microvessel densit ...... literature with meta-analysis.
@ast
The role of microvessel densit ...... literature with meta-analysis.
@en
The role of microvessel densit ...... literature with meta-analysis.
@nl
P2093
P2860
P356
P1476
The role of microvessel densit ...... literature with meta-analysis.
@en
P2093
J-J Lafitte
J-M Verdebout
J-P Sculier
M Paesmans
P Delmotte
T Berghmans
P2860
P2888
P304
P356
10.1038/SJ.BJC.6600551
P407
P577
2002-09-01T00:00:00Z
P5875
P6179
1024586147